Pre-Clinical Assessment of SAR442257, a CD38/CD3xCD28 Trispecific T Cell Engager in Treatment of Relapsed/Refractory Multiple MyelomaAnna Luise Grab, Marc S. Raab, Peter Kim et al.|Cells|2024Cited by 18
The landscape of small nucleolar RNA expression in multiple myeloma is determined by cytogenetic alterationsDuoduo Zhao, Niels Weinhold, Christian Rohde et al.|Leukemia|2023Cited by 2
PB1976: CRISPR-CAS9 KNOCKOUT SCREEN IDENTIFIES RNA MODIFICATION ENZYMES ESSENTIAL FOR CELL SURVIVAL IN MULTIPLE MYELOMADuoduo Zhao, Carsten Müller‐Tidow, Christian Rohde et al.|HemaSphere|2022Cited by 1
OAB-007: Single-cell multiomic analysis identifies regulatory programs in relapsed/refractory multiple myelomaAlexandra M. Poos, Niels Weinhold, Moritz J. Przybilla et al.|Clinical Lymphoma Myeloma & Leukemia|2021Cited by 1
P839: GAIN OF CHROMOSOME 1Q LEADS TO HIGH EXPRESSION OF SNORD78 AND ABERRANT RIBOSOME METHYLATIONDuoduo Zhao, Niels Weinhold, Christian Rohde et al.|HemaSphere|2023Cited by 0